H1N1 Influenza: Clinical Trials

13 trials for H1N1 Influenza, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 4 unknown, 3 terminated. 2 Not applicable, 2 Phase 2, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Terminated 2
Phase 22Completed 1, Terminated 1
Phase 42Completed 1, Unknown 1

Follow H1N1 Influenza: new trials by email Literature Review of H1N1 Influenza trials Research Report on H1N1 Influenza

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml
Vitamine D3 supplementation, Diet and sun exposure - Covid19, Influenza A
Not applicableTerminatedHospital Clinica Nova412020-08-052022-04-14
Tomographic Findings in COVID-19 and Influenza
Thoraxic computed tomography - SARS-CoV-2, Covid19
UnknownUniversidad de Guanajuato1002020-06-152020-08-06
Comparison of COVID-19 and H1N1 Influenza Pneumonia
computed Tomography - COVID-19, H1N1 Influenza
CompletedSecond Affiliated Hospital, Zhejiang University, School of Medicine4832017-01-012021-07-16
H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses
AS03, Influenza Virus Vaccine, Monovalent A/H3N2v A/Minnesota/11/2010 NYMC X-203, Monovalent influenza A/H7N9 virus vaccine - Avian Influenza, H1N1 Influenza
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)302016-11-072024-10-09
Serum and Bronchoalveolar Inflammatory Parameters in Patients With Severe Adult Respiratory Distress Syndrome
Empirical antimicrobial therapy - H1N1 Influenza
CompletedCentre Hospitalier Universitaire, Amiens972013-09-012026-06-24
H1N1 Vaccine Safety in Manitoba, Canada
H1N1 Influenza
UnknownInternational Centre for Infectious Diseases, Canada8000002011-06-012012-09-12
Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV
Arepanrix - HIV Infections, H1N1 Influenza
Phase 4CompletedUniversity of British Columbia1502010-02-012015-04-15
The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A
Vitamin (vitamin A 15 mg,C 500 mg, E 400IU), Placebo (digestive tablet) - H1N1 Influenza
Phase 4UnknownSeoul National University Hospital1802009-12-012010-05-20
Collaborative H1N1 Adjuvant Treatment (CHAT) Pilot Trial
Rosuvastatin or identical placebo, Placebo - H1N1 Influenza
Phase 2TerminatedCanadian Critical Care Trials Group82009-12-012013-02-26
Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza
H1N1 Influenza, Seasonal Influenza
CompletedVirginia Commonwealth University42009-11-012013-01-08
Antibody Production Following H1N1 Influenza Vaccination After Stem Cell and Heart Transplantation
H1N1 Influenza
UnknownHadassah Medical Organization3002009-11-012009-11-06
STIP: Statin Trial for Influenza Patients
Rosuvastatin (crestor), Placebo - Acute Respiratory Distress Syndrome, Influenza
Not applicableTerminatedGordon Bernard72009-10-012017-03-22
ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS
ARDS, COVID-19
CompletedUniversity of Turin, Italy3082009-08-222021-10-18

Narrower conditions

Orthomyxoviridae Infections (13)  ·  Influenza, Human (5)  ·  COVID-19 (4)  ·  HIV Infections (1)  ·  Influenza in Birds (1)  ·  Respiratory Distress Syndrome (1)

Broader conditions

Infections (13)  ·  RNA Virus Infections (13)  ·  Virus Diseases (13)  ·  Respiratory Tract Diseases (9)  ·  Respiratory Tract Infections (9)  ·  Lung Diseases (5)  ·  Coronaviridae Infections (4)  ·  Coronavirus Infections (4)  ·  Nidovirales Infections (4)  ·  Pneumonia (4)  ·  Pneumonia, Viral (4)  ·  Animal Diseases (1)  ·  Bird Diseases (1)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)

Interventions

Rosuvastatin Calcium (2)  ·  Diet (1)  ·  Digestion (1)  ·  Influenza Vaccines (1)  ·  Sugars (1)  ·  Tomography, X-Ray Computed (1)  ·  Vitamin A (1)  ·  Vitamins (1)  ·  arepanrix (1)

Sponsors

Canadian Critical Care Trials Group (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Gordon Bernard (1)  ·  Hadassah Medical Organization (1)  ·  Hospital Clinica Nova (1)  ·  International Centre for Infectious Diseases, Canada (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Seoul National University Hospital (1)  ·  Universidad de Guanajuato (1)  ·  University of British Columbia (1)  ·  University of Turin, Italy (1)  ·  Virginia Commonwealth University (1)

Countries

Canada (3)  ·  United States (3)  ·  Mexico (2)  ·  France (1)  ·  Israel (1)  ·  Italy (1)  ·  South Korea (1)

Top investigators

Allison McGeer, MD (1)  ·  Arnulfo Gonzalez-Cantu, MD (1)  ·  Brian Ward, MD (1)  ·  Chang-Hoon Lee, MD (1)  ·  Curtis Cooper, MD (1)  ·  Dan Engelhard (1)  ·  David Hasse, MD (1)  ·  David Scheifele, MD (1)  ·  Gordon R Bernard, M.D. (1)  ·  Marina Klein, MD (1)  ·  Marjolein de Wit, M.D., M.S. (1)  ·  Salah Mahmud, M.D., Ph.D. (1)  ·  Sharon Walmsley, MD (1)

Results publications

PMID 19887665, PMID 20160606, PMID 21435708, PMID 22306585, PMID 24693893, PMID 28802696, PMID 29680828, PMID 29757717, PMID 30566567, PMID 32031570, PMID 32083985, PMID 32109013, PMID 32155105, PMID 32399710, PMID 35123562, PMID 42630599